首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA‐Ramadan): a randomized trial
Authors:S. T. Azar MD  A. Echtay MD  W. M. Wan Bebakar MD  FRCP   S. Al Araj MD  A. Berrah MD  M. Omar MD  A. Mutha MD  K. Torn?e MD  PhD  M. S. Kaltoft MD  PhD  N. Shehadeh MD
Affiliation:1. Dept. of Internal Medicine, American University of Beirut Medical Centre, Beirut, Lebanon;2. Dept. of Internal Medicine, Rafik Hariri University, Beirut, Lebanon;3. Dept. of Medicine, Universiti Sains Malaysia, Penang, Malaysia;4. Obaidulla Hospital, Ras al‐Khairmah, United Arab Emirates;5. Dept. of Medicine, University Hospital Bab El Oued, Algiers, Algeria;6. Dept. of Diabetes and Endocrinology, University of KwaZulu‐Natal, KwaZulu‐Natal, Republic of South Africa;7. Diabetes Care & Research Centre, Nagpur, India;8. Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Copenhagen, Denmark;9. Pediatric Diabetes Unit at Meyer Children's Hospital, Rambam Medical Centre and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Abstract:
Keywords:body weight  fasting  fructosamine  GLP‐1  hypoglycaemia  liraglutide  metformin  Ramadan  sulphonylurea  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号